| Bioactivity | Antitumor agent-79 shows good antiproliferative activities against hepatocellular carcinoma and breast cancer cells with IC50 values of 0.7-7.9 μM. Antitumor agent-79 induces cancer cells apoptosis and shows in vivo antitumor effects. Antitumor agent-79 can be used for the research of cancer[1]. |
| Invitro | Antitumor agent-79 (0.15-40 μM; 72 h) shows in vitro growth inhibitory activities against hepatocellular carcinoma and breast cancer cells with IC50 values of 0.7-7.9 μM[1]. Antitumor agent-79 (5 μM; 48 h) induces cell apoptosis by increasing the PARP cleavage[1]. Cell Cytotoxicity Assay[1] Cell Line: |
| Name | Antitumor agent-79 |
| CAS | 2750233-50-0 |
| Formula | C23H19ClN2O |
| Molar Mass | 374.86 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Antitumor agent-79
CAS: 2750233-50-0 F: C23H19ClN2O W: 374.86
Antitumor agent-79 shows good antiproliferative activities against hepatocellular carcinoma and breast cancer cells with
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.